Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT05219929
PHASE2

Tetracycline Treatment Tolerability Trial

Sponsor: Johns Hopkins University

View on ClinicalTrials.gov

Summary

Randomized, double-blind, placebo-controlled study (with a one-week washout period) where subjects receive either 3 months of tetracycline or 3 months of placebo. After the 3 month primary endpoint, in the follow-up period, patients will be assigned to the alternate treatment for 3 months with blind maintained.

Official title: T4 - Tetracycline Treatment Tolerability Trial A Pilot Study Examining the Feasibility and Tolerability of Tetracycline Therapy in Post-Treatment Lyme Disease (PTLD)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2022-11-02

Completion Date

2027-12

Last Updated

2025-12-17

Healthy Volunteers

No

Interventions

DRUG

Tetracycline 500 Mg

500 mg three times daily

OTHER

Placebo

Placebo for Tetracycline given same way as Tetracycline.

Locations (1)

Johns Hopkins Lyme Disease Research Center

Lutherville, Maryland, United States